An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents

Liver fibrosis represents a response to chronic liver injury. Metabolic dysfunction-associated fatty liver disease and metabolic dysfunction-associated steatohepatitis are the most common chronic liver diseases, both with increasing incidence. Therefore, there is a great impetus for development of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rupcic Rubin, Vinka, Bojanic, Kristina, Smolic, Martina, Rubin, Jurica, Tabll, Ashraf, Smolic, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868700/
https://www.ncbi.nlm.nih.gov/pubmed/33604256
http://dx.doi.org/10.14218/JCTH.2020.00040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868700/
https://www.ncbi.nlm.nih.gov/pubmed/33604256
http://dx.doi.org/10.14218/JCTH.2020.00040

Ejemplares similares